EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?

  1. Antoñanzas, F. 1
  2. Juárez-Castelló, C.A. 1
  3. Rodríguez-Ibeas, R. 1
  1. 1 Universidad de La Rioja
    info

    Universidad de La Rioja

    Logroño, España

    ROR https://ror.org/0553yr311

Revue:
European Journal of Health Economics

ISSN: 1618-7598

Année de publication: 2017

Pages: 1-3

Type: Article

DOI: 10.1007/S10198-017-0944-0 SCOPUS: 2-s2.0-85035333180 GOOGLE SCHOLAR

D'autres publications dans: European Journal of Health Economics